These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17468512)

  • 21. Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer.
    Huss WJ; Lai L; Barrios RJ; Hirschi KK; Greenberg NM
    Prostate; 2004 Oct; 61(2):142-52. PubMed ID: 15305337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.
    Bethel CR; Bieberich CJ
    Prostate; 2007 Dec; 67(16):1740-50. PubMed ID: 17929276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
    Kaplan-Lefko PJ; Chen TM; Ittmann MM; Barrios RJ; Ayala GE; Huss WJ; Maddison LA; Foster BA; Greenberg NM
    Prostate; 2003 May; 55(3):219-37. PubMed ID: 12692788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
    Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
    Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials.
    Degrassi A; Russo M; Scanziani E; Giusti A; Ceruti R; Texido G; Pesenti E
    Prostate; 2007 Mar; 67(4):396-404. PubMed ID: 17187397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K; Singh RP; Agarwal R; Agarwal C
    Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
    Chau MN; El Touny LH; Jagadeesh S; Banerjee PP
    Carcinogenesis; 2007 Nov; 28(11):2282-90. PubMed ID: 17615260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
    Zhu Q; Yang J; Han S; Liu J; Holzbeierlein J; Thrasher JB; Li B
    Prostate; 2011 Jun; 71(8):835-45. PubMed ID: 21456066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Akt pathways in the treatment of prostate cancer.
    Nelson EC; Evans CP; Mack PC; Devere-White RW; Lara PN
    Prostate Cancer Prostatic Dis; 2007; 10(4):331-9. PubMed ID: 17471291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma.
    Ruddat VC; Whitman S; Klein RD; Fischer SM; Holman TR
    Prostate; 2005 Jul; 64(2):128-38. PubMed ID: 15666362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).
    Mentor-Marcel R; Lamartiniere CA; Eltoum IA; Greenberg NM; Elgavish A
    J Nutr; 2005 May; 135(5):989-95. PubMed ID: 15867270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
    Kasper S; Smith JA
    J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
    Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
    Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
    Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.
    Martiniello-Wilks R; Dane A; Mortensen E; Jeyakumar G; Wang XY; Russell PJ
    Anticancer Res; 2003; 23(3B):2633-42. PubMed ID: 12894551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model.
    Bok RA; Hansell EJ; Nguyen TP; Greenberg NM; McKerrow JH; Shuman MA
    Prostate Cancer Prostatic Dis; 2003; 6(4):272-80. PubMed ID: 14663466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.
    Jagadeesh S; Banerjee PP
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1361-7. PubMed ID: 16979586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.